Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept Monotherapy T&E for DME in Taiwan
NCT04288232Phase 3Completed
- Sponsor
- Taipei Veterans General Hospital
- Start
- Aug 2015
- Primary completion
- Nov 2017
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
01
Overview
A Phase 3 trial of aflibercept in diabetic macular edema (DME), sponsored by Taipei Veterans General Hospital. Started Aug 2015; status: completed.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04288232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04288232.